(Q40318203)

19 September 2017

Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors (English)

1 reference

19 September 2017

Klaus-Michael Debatin

9

object named as

Debatin KM

1 reference

19 September 2017

Wenger T

1

1 reference

19 September 2017

Mattern J

2

1 reference

19 September 2017

Penzel R

3

1 reference

19 September 2017

Gassler N

4

1 reference

19 September 2017

Haas TL

5

1 reference

19 September 2017

Sprick MR

6

1 reference

19 September 2017

Walczak H

7

1 reference

19 September 2017

Krammer PH

8

1 reference

19 September 2017

Herr I

10

1 reference

19 September 2017

10 February 2006

1 reference

Cell Death & Differentiation

19 September 2017

1 reference

19 September 2017

13

1 reference

19 September 2017

1740-1751

1 reference

19 September 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401867

19 September 2017

0 references

cites work

AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Apo2L/TRAIL and its death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Induction of apoptosis in experimental human B cell lymphomas by conditional TRAIL-expressing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Lentiviral vectors: turning a deadly foe into a therapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Harnessing HIV for therapy, basic research and biotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Retroviral membrane display of apoptotic effector molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Fluorescent conjugates of brefeldin A selectively stain the endoplasmic reticulum and Golgi complex of living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Green fluorescent protein: green cells do not always indicate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

TRAIL-induced apoptosis and gene induction in HaCaT keratinocytes: differential contribution of TRAIL receptors 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Subcellular redistribution of Pit-2 P(i) transporter/amphotropic leukemia virus (A-MuLV) receptor in A-MuLV-infected NIH 3T3 fibroblasts: involvement in superinfection interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Molecular ordering of the initial signaling events of CD95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

c-FLIPR, a new regulator of death receptor-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

7 January 2021

Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401867

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4401867

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference